Nouvel Hôpital Civil (NHC)
Strasbourg 67091
2 studies enrolling now · 3 studies all time
What they study most
Carcinoma, Non-Small-Cell Lung, Metabolic Dysfunction-Associated Steatotic Liver Disease, Neoplasm Metastasis, Ulcerative Colitis
Studies at this site
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
- A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
- A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling